Alethea Capital Management reduced its CVS Health Co. stock position by 69.7%, while Royal Bank of Canada increased its stake by 2.2%.
Alethea Capital Management LLC reduced its stock position in CVS Health Co. by 69.7% during the third quarter, holding 3,300 shares after selling 7,604 shares. Royal Bank of Canada increased its stake in CVS by 2.2%, owning 14,136,920 shares after purchasing an additional 303,512 shares. CVB Financial Corp. received a consensus recommendation of "Hold" from the five analysts covering the firm, with an average 1-year target price of $20.00.
March 06, 2024
6 Articles